AFLFinancial Services · Insurance - LifeThe 15 Wall Street analysts covering Aflac, Inc. hold a median 12-month price target of $116 — -7.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 79 of 100 as at 3 Nov 2026 — inside the top quartile. The factors read stronger than the Street's target implies. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Aflac, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Growth (97): Sales and profits are climbing, and climbing faster than before.
Value (39): The shares cost a lot relative to the profits and assets behind them.
Size (4): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on AFL, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits −7.5% from it.
Of the 20 most recent actions, 6 moved their price target up and 4 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 15 Oct 2026 | JP Morgan | Maintains | Neutral | $116 → $119 |
| 12 Oct 2026 | Wells Fargo | Maintains | Equal-Weight | $122 → $116 |
| 9 Oct 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | $125 → $120 |
| 7 Oct 2026 | Barclays | Maintains | Underweight | $99 → $101 |
| 7 Oct 2026 | Barclays | Maintains | Underweight | — |
| 7 Oct 2026 | Mizuho | Maintains | Underperform | — |
| 7 Oct 2026 | Mizuho | Maintains | Underperform | $116 → $107 |
| 6 Oct 2026 | UBS | Maintains | Neutral | — |
| 6 Oct 2026 | UBS | Maintains | Neutral | $124 → $125 |
| 19 Aug 2026 | Wells Fargo | Maintains | Equal-Weight | $120 → $122 |
| 19 Aug 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 19 Aug 2026 | Wolfe Research | Initiates | Underperform | — |
| 19 Aug 2026 | Wolfe Research | Initiates | Underperform | $103 |
| 11 Aug 2026 | JP Morgan | Maintains | Neutral | $117 → $116 |
| 11 Aug 2026 | JP Morgan | Maintains | Neutral | — |
| 11 Aug 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | $120 → $125 |
| 11 Aug 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | — |
| 10 Aug 2026 | Mizuho | Maintains | Underperform | — |
| 10 Aug 2026 | Piper Sandler | Maintains | Overweight | — |
| 10 Aug 2026 | Piper Sandler | Maintains | Overweight | $130 → $138 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
AFL appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, Aflac, Inc. returned +17.6% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 49% of US stocks
Cheaper than 34% of US stocks
Cheaper than 42% of US stocks
Cheaper than 33% of US stocks
Higher than 26% of US stocks
Higher than 70% of US stocks
Higher than 84% of US stocks
Higher than 87% of US stocks
Higher than 77% of US stocks
Higher than 66% of US stocks
Higher than 79% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Aflac, Inc. has a market value of $62.2B and an enterprise value of $69.7B.
Revenue in the twelve months to 30 June 2026: $18.3B. The latest quarter shrank 1.0% year on year.
Net income over the same four quarters: $4.9B, a 26.6% net margin.
Diluted earnings per share, trailing twelve months: $9.33.
Free cash flow in the twelve months to 30 June 2026: $2.6B.
Aflac, Inc. spent $3.8B on share buybacks and $1.2B on dividends in the twelve months to 30 June 2026.
Trailing P/E: 13.3×; forward P/E: 16.3× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 1.97%, paying out 26% of earnings.
Aflac, Inc. employs 12,716 people — $1.4M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Aflac, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research says Aflac’s Q3 headline results for the quarter ended September 2026 offer a view of its performance, and highlights comparing key metrics with Wall Street estimates and year-ago actuals.
Why it matters — Aflac watchers may use the comparisons to assess quarterly performance against expectations and the prior year.
Aflac reported quarterly earnings of $2.43 per share, above the Zacks Consensus Estimate of $1.80. Earnings were $2.49 per share in the year-ago quarter.
Why it matters — The results show Aflac exceeded the consensus earnings estimate, while per-share earnings were lower than a year earlier.
Aflac Incorporated reported its third-quarter 2026 results and declared a fourth-quarter dividend.
Why it matters — The results and dividend declaration are company updates relevant to investors following AFL.
Insurers are coming into focus as third-quarter 2026 earnings are reported. Marsh, Aon and The Hartford have already posted solid year-over-year growth, providing an early read on the industry.
Why it matters — AFL watchers may view the results from other insurers as early context for the sector, though the excerpt provides no AFL-specific earnings information.
Aflac released its 2026 Holiday Duck, marking 25 years of the collectible tradition. The company says the tradition helps bring comfort, hope and support to children with cancer and blood disorders.
Why it matters — The anniversary highlights Aflac’s community-support efforts alongside its supplemental health insurance business.
The 15 Wall Street analysts covering Aflac, Inc. have a median 12-month price target of $116, with estimates ranging from $101 to $138. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 15 analysts covering Aflac, Inc., 3 rate it a Buy, 8 a Hold and 4 a Sell. Ticker Nerd's systematic factor model ranks Aflac, Inc. 79 out of 100 across roughly 4,600 US stocks as at 3 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 3 Nov 2026, Aflac, Inc. ranks 79 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (97 of 100).
No one can know that. What the data says: the median 12-month target from 15 analysts implies -7.5% from the last close, and Ticker Nerd's factor model ranks Aflac, Inc. 79 out of 100 as at 3 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Aflac, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AFL are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $101 to $138 over the next 12 months.
Aflac, Inc. returned +17.6% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Aflac Incorporated is a life and health insurance holding company that provides supplemental financial protection through its subsidiaries in the United States and Japan. The company specializes in cash-benefit insurance products that help policyholders cover out-of-pocket costs associated with illness, injury, hospitalization, disability, and other covered events.
The most recent item we track (Zacks Investment Research, 5 Nov 2026): "Aflac (AFL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates". Zacks Investment Research says Aflac’s Q3 headline results for the quarter ended September 2026 offer a view of its performance, and highlights comparing key metrics with Wall Street estimates and year-ago actuals.
Aflac Incorporated is a life and health insurance holding company that provides supplemental financial protection through its subsidiaries in the United States and Japan. The company specializes in cash-benefit insurance products that help policyholders cover out-of-pocket costs associated with illness, injury, hospitalization, disability, and other covered events. Its portfolio includes supplemental health, cancer, accident, critical illness, hospital indemnity, disability, dental, vision, and life insurance, along with related voluntary benefit solutions for individuals, families, and employers. Aflac Incorporated operates through two main business segments, Aflac Japan and Aflac U.S., and distributes products through independent agents, brokers, banks, corporate agencies, and workplace channels. The company plays a significant role in the supplemental insurance market by complementing primary medical coverage and helping customers manage everyday health-related financial risks.
CEO Mr. Daniel Paul Amos · 12,716 employees · United States · https://www.aflac.com
